PureTech Health

Bio-Pharma

Deupirfenidone Shows Strong IPF Results in Phase 2b Study

NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...

By cGxPwire Editor
April 3, 2026

Bio-Pharma

PureTech, Seaport Advance GlyphAllo in Depression Therapy

BOSTON, Massachusetts, March 26, 2026 PureTech Health has announced that its founded entity, Seaport Therapeutics, has published first-in-human clinical...

By cGxPwire Editor
March 26, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

PureTech Health

Deupirfenidone Shows Strong IPF Results in Phase 2b Study

PureTech, Seaport Advance GlyphAllo in Depression Therapy